These ASX 200 shares could rise 25% to 60%

Big returns could be on the cards for buyers of these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you hunting big returns for your investment portfolio?

If you are, then don't miss out on the ASX 200 shares listed below that analysts have named as buys and tipped to rise strongly from current levels.

Here's what you need to know:

A woman presenting company news to investors looks back at the camera and smiles.

Image source: Getty Images

CSL Ltd (ASX: CSL)

The team at Bell Potter sees significant value in CSL shares at current levels.

The broker has a buy rating and $335.00 price target on the biotechnology company's shares. This implies potential upside of approximately 28% for investors over the next 12 months.

Commenting on the ASX 200 share, the broker said:

While the declining US flu market has caused headwinds for Seqirus, Behring continues its strong growth outlook and positive margin recovery, which we expect will continue to drive double digit earnings growth for the group over the mid-term.

HMC Capital Ltd (ASX: HMC)

Another ASX 200 share that could be a buy according to analysts is this diversified alternative asset manager.

That's the view of analysts at Goldman Sachs, which have just put a buy rating and $12.30 price target on its shares. This suggests that upside of 25% is possible for investors.

It likes the company due to its growth strategy and recent diversification away from traditional real estate. It said:

We are Buy rated given HMC's FUM growth strategy and diversification away from classic Real Estate and into Digital Infrastructure (including DigiCo) among various other strategies including Energy Transition and Private markets.

On the latter we see four key factors supporting FUM growth in the medium term, including: i) increased investor allocation to private markets, ii) a positive skew in borrower preferences to private credit, iii) a structural shift in the public markets to larger deal sizes, and iv) an acceleration in commercial real estate credit due to Australia's undersupply of housing stock.

Iluka Resources Limited (ASX: ILU)

Finally, Goldman Sachs also sees significant value on offer from this mineral sands and rare earths company's shares.

The broker has a buy rating and $7.00 price target on them. This implies potential upside of approximately 60% for investors over the next 12 months.

Speaking about Iluka, the broker said:

Compelling Mineral Sands FCF and Rare Earth growth potential: ILU is trading on a FCF yield of ~20% in 2026E without the RE refinery capex. We are positive on ILU's project pipeline and forecast >20% production growth in mineral sands volumes, ~18ktpa of Rare Earths (~4ktpa of high value NdPr) over the next 5yrs. We think ILU's Eneabba RE refinery is a strategic asset considering it will be only the fifth Western World RE refinery.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goldman Sachs Group, and HMC Capital. The Motley Fool Australia has recommended CSL and HMC Capital. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »